ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CTMX CytomX Therapeutics Inc

4.44
-0.06 (-1.33%)
Pre Market
Last Updated: 18:21:54
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
CytomX Therapeutics Inc CTMX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.06 -1.33% 4.44 18:21:54
Open Price Low Price High Price Close Price Previous Close
4.50
more quote information »

Recent News

Date Time Source Heading
01/5/202422:00GLOBECytomX Therapeutics to Report First Quarter 2024 Results and..
08/4/202422:00GLOBECytomX Therapeutics Announces First Patient Dosed with..
03/4/202423:00GLOBECytomX Therapeutics Announces Nomination of Second Clinical..
21/3/202423:00GLOBECytomX Therapeutics Appoints Dr. Zhen Su to Board of..
18/3/202423:00GLOBECytomX Therapeutics Announces Milestone Achievement in..
12/3/202407:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/3/202407:10GLOBECytomX Therapeutics Reports 2023 Financial Results and..
12/3/202407:02EDGAR2Form 8-K - Current report
12/3/202407:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202421:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
05/3/202400:00GLOBECytomX Therapeutics to Report Fourth Quarter and Full Year..
28/2/202400:00GLOBECytomX Therapeutics to Present at Upcoming March Investor..
25/1/202400:00GLOBECytomX Therapeutics Announces FDA Clearance of IND..
20/1/202412:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202412:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202412:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202412:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202412:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202400:00GLOBECytomX Therapeutics to Present at the B. Riley Securities..
05/1/202400:00GLOBECytomX Therapeutics Outlines 2024 Company Priorities and..
23/12/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202308:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202308:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202300:00GLOBECytomX Therapeutics to Present at the 42nd Annual J.P...
20/12/202311:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202311:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202311:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202311:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202308:15GLOBECytomX Therapeutics Reports Third Quarter 2023 Financial..
08/11/202308:05EDGAR2Form 8-K - Current report
08/11/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202323:00GLOBECytomX Therapeutics to Present at Upcoming November Investor..
31/10/202323:00GLOBECytomX Therapeutics to Report Third Quarter 2023 Financial..
30/10/202323:00GLOBECytomX Therapeutics to Present Preclinical Data for..
19/10/202307:30GLOBECytomX Therapeutics Presents Preclinical Profile of..
23/9/202309:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202309:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202309:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202306:05GLOBECytomX Therapeutics to Present at Upcoming September..
28/8/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
25/8/202306:05EDGAR2Form 8-K - Current report
16/8/202311:40EDGAR2Form S-3 - Registration statement under Securities Act of..
11/8/202306:05GLOBECytomX Therapeutics to Present at the H.C. Wainwright Immune..
09/8/202306:15GLOBECytomX Therapeutics Reports Second Quarter 2023 Financial..
09/8/202306:08EDGAR2Form 8-K - Current report
09/8/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202322:00GLOBECytomX Therapeutics to Report Second Quarter 2023 Financial..
21/7/202307:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/7/202307:17EDGAR2Form 3 - Initial statement of beneficial ownership of..

Your Recent History

Delayed Upgrade Clock